Spotlight on Immunotherapy of Mismatch Repair Deficient Tumors

Share
Print
Luis Diaz, MD

Luis Diaz, MD

The July 22 MSK Science Spotlight features Luis Diaz, MD, Head of the Division of Solid Tumor Oncology and Grayer Family Chair, presenting his work on ”Immunotherapy of Mismatch Repair Deficient Tumors.” An accomplished physician, pioneering researcher, and leader in the field of clinical oncology, Dr. Diaz has recently been recognized for his novel applications of cancer genomics and circulating tumor DNA for early cancer detection as well as prognosis and recurrence prediction, and for his groundbreaking work involving immune checkpoint blockade in DNA mismatch repair deficient tumors. The July 22 lecture will be hosted by Omar Abdel-Wahab, MD Associate Member, Human Oncology and Pathogenesis Program; Associate Attending, Leukemia Service; Director, MSK Center for Hematologic Malignancies.

MSK Science Spotlight
“MSK Science Spotlight” seminars take place every Monday and Wednesday at 4:30 pm ET and are 60 minutes, including 15 minutes for Q&A. Detailed information about seminar speakers, dates, and times as well as live streams and recorded video are available here.